CHP
ABEO icon

Castle Hook Partners’s Abeona Therapeutics ABEO Stock Holding History

Castle Hook Partners’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,200
Closed -$8.18M – 56
2017
Q3 		$8.18M Buy
+19,200
New +$5.16M 0.27% 42

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Castle Hook Partners's ABEO Position: Q1 2018 in Review

Castle Hook Partners sold out of Abeona Therapeutics (ABEO) in Q1 2018, closing a stake of 47,604 shares — an estimated $18.9M sold.

Castle Hook Partners first reported a position in ABEO in Q4 2016 and held it in 5 quarters. The position peaked at $23.4M in Q3 2017. 88 funds tracked by Wall St. Rank hold ABEO as of Q1 2018.

  • Castle Hook Partners reported no remaining Abeona Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Castle Hook Partners sold 47,604 Abeona Therapeutics shares in Q1 2018, an estimated $18.9M.
  • Castle Hook Partners first reported a position in Abeona Therapeutics in Q4 2016 and held it in 5 quarters.
  • Castle Hook Partners's Abeona Therapeutics position peaked at $23.4M in Q3 2017.
  • 88 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2018.

Based on Castle Hook Partners's 13F filing for Q1 2018, filed 15 May 2018.